CVR 33971176Public limited company (A/S)Engroshandel med læge- og hospitalsartikler (464620)Islands Brygge 43, 2300 København SFounded 15 Oct 2011
Compare withsimilar companiesanother companyits industry
ARTHREX DANMARK A/S
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about ARTHREX DANMARK A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
24
CVR, Aug 2026
-1 (-4%) over 12 months
Gross profit
38.4M
DKK, annual report 2026
+16.6% on 2025
Result
+9.7M
DKK, annual report 2026
Equity
47M
DKK, annual report 2026
Arthrex GmbH100% of capital and votes
Operating company
Dandex estimate: 24 employees registered in 2026Philip Axel Johannes Almsince 2 Jan 2023
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 15 Oct 2011
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Aug 2026, monthly: 24 employees, 22 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2012 | 2013 | 2014 | Jan 2015 | Feb 2015 | Mar 2015 | Apr 2015 | May 2015 | Jun 2015 | Jul 2015 | Aug 2015 | Sep 2015 | Oct 2015 | Nov 2015 | Dec 2015 | Jan 2016 | Feb 2016 | Mar 2016 | Apr 2016 | May 2016 | Jun 2016 | Jul 2016 | Aug 2016 | Sep 2016 | Oct 2016 | Nov 2016 | Dec 2016 | Jan 2017 | Feb 2017 | Mar 2017 | Apr 2017 | May 2017 | Jun 2017 | Jul 2017 | Aug 2017 | Sep 2017 | Oct 2017 | Nov 2017 | Dec 2017 | Jan 2018 | Feb 2018 | Mar 2018 | Apr 2018 | May 2018 | Jun 2018 | Jul 2018 | Aug 2018 | Sep 2018 | Oct 2018 | Nov 2018 | Dec 2018 | Jan 2019 | Feb 2019 | Mar 2019 | Apr 2019 | May 2019 | Jun 2019 | Jul 2019 | Aug 2019 | Sep 2019 | Oct 2019 | Nov 2019 | Dec 2019 | Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | Jul 2020 | Aug 2020 | Sep 2020 | Oct 2020 | Nov 2020 | Dec 2020 | Jan 2021 | Feb 2021 | Mar 2021 | Apr 2021 | May 2021 | Jun 2021 | Jul 2021 | Aug 2021 | Sep 2021 | Oct 2021 | Nov 2021 | Dec 2021 | Jan 2022 | Feb 2022 | Mar 2022 | Apr 2022 | May 2022 | Jun 2022 | Jul 2022 | Aug 2022 | Sep 2022 | Oct 2022 | Nov 2022 | Dec 2022 | Jan 2023 | Feb 2023 | Mar 2023 | Apr 2023 | May 2023 | Jun 2023 | Jul 2023 | Aug 2023 | Sep 2023 | Oct 2023 | Nov 2023 | Dec 2023 | Jan 2024 | Feb 2024 | Mar 2024 | Apr 2024 | May 2024 | Jun 2024 | Jul 2024 | Aug 2024 | Sep 2024 | Oct 2024 | Nov 2024 | Dec 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 8 | 7 | 12 | 14 | 14 | 13 | 13 | 12 | 10 | 11 | 10 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 12 | 12 | 13 | 13 | 13 | 12 | 13 | 13 | 13 | 13 | 13 | 13 | 12 | 11 | 10 | 12 | 13 | 13 | 12 | 13 | 12 | 14 | 14 | 14 | 16 | 15 | 13 | 13 | 12 | 14 | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 16 | 15 | 14 | 14 | 16 | 15 | 13 | 16 | 16 | 15 | 14 | 15 | 15 | 14 | 14 | 14 | 15 | 14 | 13 | 11 | 15 | 14 | 15 | 15 | 16 | 15 | 15 | 14 | 15 | 14 | 14 | 16 | 16 | 17 | 18 | 18 | 18 | 19 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 19 | 19 | 18 | 19 | 19 | 21 | 20 | 21 | 22 | 23 | 24 | 24 | 24 | 25 | 24 | 25 | 24 | 25 | 24 | 23 | 23 | 22 | 23 | 24 | 24 | 24 | 25 | 26 | 25 | 26 | 25 | 24 | 25 | 26 | 24 | 25 | 25 | 25 | 24 |
| FTE | 6 | 6 | 8 | 10 | 11 | 10 | 10 | 10 | 9 | 9 | 8 | 9 | 10 | 10 | 10 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 8 | 7 | 8 | 9 | 10 | 9 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 12 | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 10 | 12 | 11 | 12 | 12 | 12 | 13 | 11 | 12 | 11 | 11 | 12 | 13 | 13 | 14 | 14 | 15 | 15 | 15 | 17 | 17 | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 18 | 18 | 18 | 19 | 19 | 20 | 20 | 21 | 21 | 22 | 22 | 23 | 23 | 23 | 22 | 23 | 22 | 23 | 22 | 21 | 22 | 21 | 22 | 22 | 23 | 21 | 24 | 25 | 24 | 24 | 24 | 23 | 24 | 25 | 23 | 24 | 24 | 23 | 22 |
| Series | Annual | Annual | Annual | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly | Monthly |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group. CVR changed its monthly method in Oct 2019: a step there need not be real.
Source: CVR, latest Aug 2026, published 21 Oct 2026.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2026, DKK: Gross profit 38.4M, Operating profit 13M, Result for the year 9.7M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2026, DKK: Total assets 59.6M, Equity 47M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Gross profit | 21,312 | 29,862 | 29,900 | 32,972 | 38,444 |
| Operating profit | +4,065 | +10,789 | +9,606 | +10,106 | +12,971 |
| Result for the year | +2,876 | +8,300 | +7,368 | +7,539 | +9,676 |
| Equity | 14,108 | 22,408 | 29,776 | 37,315 | 46,991 |
| Total assets | 37,799 | 38,769 | 47,155 | 52,710 | 59,646 |
| Employees (average) | 13 | 17 | 21 | 22 | 24 |
Annual report 2026
1 Jul 2025 to 30 Jun 2026, published 10 Nov 2026
Annual report 2025
1 Jul 2024 to 30 Jun 2025, published 18 Sep 2025
Annual report 2024
1 Jul 2023 to 30 Jun 2024, published 18 Sep 2024
Annual report 2023
1 Jul 2022 to 30 Jun 2023, published 3 Oct 2023
Annual report 2022
1 Jul 2021 to 30 Jun 2022, published 31 Oct 2022
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 500,000, cash price 500.00, implied value 250,500,000 | 500.00 | 500,000 | 250,500,000 | 501,000 | |
| FoundingCashPaid in 500,000 | None | 500,000 | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Gross profit growth (vækst i bruttofortjeneste) | -9.6% | 40.1% | 0.1% | 6% | 16.6% |
| EBITDA | 8,193 | 14,598 | 12,902 | 13,876 | 16,890 |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Employee growth (vækst i antal ansatte) | 0% | 30.8% | 23.5% | 4.8% | 9.1% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | 3,187note 1 | 3,481note 1 | 5,593note 1 | 4,888note 1 | 4,392note 1 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 21 Nov 2026.
11 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Ny adresse: Islands Brygge 43, 2., 2300 København S
Bestyrelse:
Fratrådte:
Geert Jos Marcel Onan, den 22.05.2024.
Bestyrelse:
Fratrådte:
Stefan Hans Josef Krupp, (formand), den 01.01.2023, Torgeir Erlandsen, den 02.01.2023.
Tiltrådte:
Philip Axel Johannes Alm, den 02.01.2023, Torgeir Erlandsen, (formand), den 02.01.2023.
Direktion:
Vedtægter ændret: 12.12.2022
Selskabet tegnes af et medlem af bestyrelsen eller et medlem af direktionen.
Revision:
Fratrådte:
EY Godkendt Revisionspartnerselskab, den 15.03.2022.
Tiltrådte:
CVR-NR. 14119299 PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, 2600 Glostrup, den 15.03.2022.
Revision:
Fratrådte:
PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 31.05.2020.
Tiltrådte:
CVR-NR. 30700228 EY Godkendt Revisionspartnerselskab, Dirch Passers Allé 36, 2000 Frederiksberg, den 01.06.2020.
Ny adresse: Islands Brygge 39, 1., 2300 København S
Bestyrelse:
Fratrådte:
Johannes Maximilian Schäferhoff, den 30.06.2017.
Tiltrådte:
Torgeir Erlandsen, den 12.06.2017.
Ny adresse:
Islands Brygge 43, 2300 København S.
Vedtægter ændret:
07.11.2011.
Nyt navn:
ARTHREX DANMARK A/S.
Kapitalforhøjelse:
kr. 1.000,00 indbetalt kontant, kurs 50.000,00.
Kapitalen udgør herefter kr. 501.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Jørgen Herman Melchior, den 09.11.2011, Lone Annette Saul Stakemann, den 09.11.2011, Peter Andreas Stakemann, den 09.11.2011.
Indtrådt i bestyrelsen:
Stefan Hans Josef Krupp (formand), den 09.11.2011, Geert Jos Marcel Onan, den 09.11.2011, Johannes Maximilian Schäferhoff, den 09.11.2011.
Direktion:
Udtrådt af direktionen:
Peter Andreas Stakemann, den 09.11.2011.
Indtrådt i direktionen:
Timothy Francis Egan, den 09.11.2011.
Selskabet tegnes af den samlede bestyrelse eller af to bestyrelsesmedlemmer sammen eller af et bestyrelsesmedlem og en direktør. Dog kan hvert bestyrelsesmedlem eller en direktør tegne selskabet alene i forhold, der vedrører værdier op EUR 25.000 eller den tilsvarende værdi i DKK.
Revision:
Udtrådt af revisionen:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, den 09.11.2011.
Indtrådt i revisionen:
CVR-NR. 14119299 PKF MUNKEBO VINDELEV, STATSAUTORISERET REVISIONSAKTIESELSKAB, Hovedvejen 56, 2600 Glostrup, den 09.11.2011.
Stiftelsesdato:
15.10.2011.
Seneste vedtægtsdato:
15.10.2011.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
Indbetalt kontant kr. 500.000,00 til kurs 100,00.
Stifter:
CVR-NR. 13469938 AKTIESELSKABET STAKEMANN, Kronprinsessegade 18, 1306 København K, den 15.10.2011.
Bestyrelse:
Jørgen Herman Melchior (formand), den 15.10.2011, Lone Annette Saul Stakemann, den 15.10.2011, Advokat Peter Andreas Stakemann, den 15.10.2011.
Direktion:
Advokat Peter Andreas Stakemann, den 15.10.2011.
Selskabet tegnes af den samlede bestyrelse eller af en direktør alene.
Revision:
BDO STATSAUTORISERET REVISIONSAKTIESELSKAB, Havneholmen 29, 1., 1561 København V, den 15.10.2011.
Første regnskabsår:
15.10.2011 - 30.06.2012.
Regnskabsår:
01.07 - 30.06.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 21 Nov 2026.
What Pro holds for ARTHREX DANMARK A/S:
Have Pro? Sign in.
P-number 1017222771Islands Brygge 43, 2300 København S
No other current company drawn.
No other current company drawn.